Stock Events

Stock Events

NovaBridge Biosciences. 

$1.9195
82
-$0.01-0.54% 08:12 Today

Statistics

Day High
1.95
Day Low
1.94
52W High
6.79
52W Low
1.46
Volume
15,165
Avg. Volume
-
Mkt Cap
223.2M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-10.97MNet Income

Analyst Ratings

9.00Average Price Target
The highest estimate is 9.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NBP. It's not an investment recommendation.
Bitcoin
2
BTC.CRYPTO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zai Lab Limited
ZLAB
Mkt Cap2.91B
Zai Lab operates in the same therapeutic areas as I-Mab, including oncology and autoimmune diseases, making them direct competitors.
CytomX Therapeutics
CTMX
Mkt Cap732.14M
CytomX Therapeutics is involved in developing antibody therapeutics for cancer, similar to I-Mab's focus, positioning them as competitors.
Sana Biotechnology
SANA
Mkt Cap1.06B
Sana Biotechnology competes with I-Mab in the biotech space, focusing on engineering cells to create therapies that could overlap with I-Mab's work.
Novartis
NVS
Mkt Cap286.78B
Novartis is a large pharmaceutical company with a broad oncology portfolio, competing with I-Mab in cancer treatment research and development.
Merck
MRK
Mkt Cap335.14B
Merck is a global healthcare company with a strong emphasis on cancer treatments, directly competing with I-Mab's oncology focus.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol Myers Squibb has a significant presence in the oncology and immunoscience sectors, making it a competitor to I-Mab.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences has a diverse range of therapeutic products, including oncology and inflammatory diseases, areas where I-Mab is also active.
AMGEN
AMGN
Mkt Cap224.63B
Amgen focuses on human therapeutics, including oncology and hematology, which are key areas of focus for I-Mab.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals is involved in developing treatments for cancer and other diseases, competing with I-Mab in the biopharmaceutical field.

About

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
Show more...
CEO
Srishti Gupta
Employees
30
Country
United States
ISIN
US44975P1030
WKN
000A2PVC6

Listings

F
DE
0VY.F
STU
DE
0VY.STU
XNAS
US
NBP
BOATS
BOATS
NBP.BOATS

0 Comments

Share your thoughts

FAQ

What is NovaBridge Biosciences. stock price today?▼
The current price of NBP is $1.92 USD — it has decreased by -0.54% in the past 24 hours. Watch NovaBridge Biosciences. stock price performance more closely on the chart.
What is NovaBridge Biosciences. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange NovaBridge Biosciences. stocks are traded under the ticker NBP.
What is NovaBridge Biosciences. market cap?▼
Today NovaBridge Biosciences. has the market capitalization of 223.2M
What is NovaBridge Biosciences. revenue for the last year?▼
NovaBridge Biosciences. revenue for the last year amounts to 0 USD.
What is NovaBridge Biosciences. net income for the last year?▼
NBP net income for the last year is -10.97M USD.
How many employees does NovaBridge Biosciences. have?▼
As of August 18, 2026, the company has 30 employees.
In which sector is NovaBridge Biosciences. located?▼
NovaBridge Biosciences. operates in the Health & Wellness sector.
When did NovaBridge Biosciences. complete a stock split?▼
NovaBridge Biosciences. has not had any recent stock splits.
Where is NovaBridge Biosciences. headquartered?▼
NovaBridge Biosciences. is headquartered in Rockville, United States.